OncoFirm™ CEA
Rapid Lateral Flow Immunoassay for Carcinoembryonic Antigen (CEA) Investigational device in the United States. OncoFirm™ CEA has not been cleared or approved by the U.S. Food and Drug Administration and…
-
-
OncoFirm™ PSA
Rapid Lateral Flow Immunoassay for Total Prostate-Specific Antigen (PSA) Investigational device in the United States. OncoFirm™ PSA has not been cleared or approved by the U.S. Food and Drug Administration…